Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
ACS Chem Neurosci. 2013 Jan 16;4(1):122-9. doi: 10.1021/cn3000873. Epub 2012 Sep 22.
Experiments were designed to determine the cause of the selective dysfunction of G(i) proteins, characterized by a reduced endothelium-dependent relaxation to serotonin (5-hydroxytryptamine), in coronary arteries lined with regenerated endothelial cells. Part of the endothelium of the left anterior descending coronary artery of female pigs was removed in vivo to induce regeneration. The animals were treated chronically with vehicle (control), apocynin (antioxidant), or BMS309403 (A-FABP inhibitor) for 28 days before functional examination and histological analysis of segments of coronary arteries with native or regenerated endothelium of the same hearts. Isometric tension was recorded in organ chambers and cumulative concentration-relaxation curves obtained in response to endothelium-dependent [serotonin (G(i) protein mediated activation of eNOS) and bradykinin (G(q) protein mediated activation of eNOS)] and independent [detaNONOate (cGMP-mediated), isoproterenol (cAMP-mediated)] vasodilators. The two inhibitors tested did not acutely affect relaxations of preparations with either native or regenerated endothelium. In the chronically treated groups, however, both apocynin and BMS309403 abolished the reduction in relaxation to serotonin in segments covered with regenerated endothelium and prevented the intima-medial thickening caused by endothelial regeneration, without affecting responses to bradykinin or endothelium-independent agonists (detaNONOate and isoproterenol). Thus, inhibition of either oxidative stress or A-FABP likely prevents both the selective dysfunction of G(i) protein mediated relaxation to serotonin and the neointimal thickening resulting from endothelial regeneration.
实验旨在确定导致冠状动脉中 G(i) 蛋白选择性功能障碍的原因,这种功能障碍的特征是对 5-羟色胺(5-羟色胺)的内皮依赖性松弛减少,而这些冠状动脉的内皮细胞已经再生。通过在体内去除雌性猪的左前降支冠状动脉的一部分来诱导内皮细胞再生。这些动物在功能检查和具有相同心脏的天然或再生内皮的冠状动脉段的组织学分析之前,用载体(对照)、阿朴肉桂酸(抗氧化剂)或 BMS309403(A-FABP 抑制剂)进行慢性治疗 28 天。在器官室中记录等长张力,并获得对内皮依赖性[5-羟色胺(G(i) 蛋白介导的 eNOS 激活)和缓激肽(G(q) 蛋白介导的 eNOS 激活)]和独立[detanoNOate(cGMP 介导),异丙肾上腺素(cAMP 介导)]血管扩张剂的累积浓度-松弛曲线。两种测试的抑制剂均不会急性影响具有天然或再生内皮的制剂的松弛作用。然而,在慢性治疗组中,阿朴肉桂酸和 BMS309403 均消除了再生内皮覆盖的节段中对 5-羟色胺的松弛减少,并防止了内皮再生引起的内膜-中膜增厚,而不影响对缓激肽或内皮非依赖性激动剂(detanoNOate 和异丙肾上腺素)的反应。因此,抑制氧化应激或 A-FABP 可能会预防 G(i) 蛋白介导的 5-羟色胺松弛的选择性功能障碍以及内皮再生引起的新生内膜增厚。